These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25971463)

  • 1. Hip Dysfunction and Quality of Life in Patients With Sickle Cell Disease.
    Malheiros CD; Lisle L; Castelar M; Sá KN; Matos MA
    Clin Pediatr (Phila); 2015 Dec; 54(14):1354-8. PubMed ID: 25971463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease.
    Connolly ME; Bills SE; Hardy SJ
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27823. PubMed ID: 31131984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising outcome of a hip school for patients with hip dysfunction.
    Klässbo M; Larsson G; Harms-Ringdahl K
    Arthritis Rheum; 2003 Jun; 49(3):321-7. PubMed ID: 12794786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment adherence and quality of life outcomes in patients with sickle cell disease.
    Al Jaouni SK; Al Muhayawi MS; Halawa TF; Al Mehayawi MS
    Saudi Med J; 2013 Mar; 34(3):261-5. PubMed ID: 23475090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease.
    Schlenz AM; Schatz J; McClellan CB; Roberts CW
    J Pediatr Psychol; 2012 Aug; 37(7):798-807. PubMed ID: 22467881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not.
    Nwenyi E; Leafman J; Mathieson K; Ezeobah N
    Int J Health Care Qual Assur; 2014; 27(6):468-81. PubMed ID: 25115050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study.
    Adeyemo TA; Ojewunmi OO; Diaku-Akinwumi IN; Ayinde OC; Akanmu AS
    Pediatr Blood Cancer; 2015 Jul; 62(7):1245-51. PubMed ID: 25810358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33).
    Mohtadi NG; Griffin DR; Pedersen ME; Chan D; Safran MR; Parsons N; Sekiya JK; Kelly BT; Werle JR; Leunig M; McCarthy JC; Martin HD; Byrd JW; Philippon MJ; Martin RL; Guanche CA; Clohisy JC; Sampson TG; Kocher MS; Larson CM;
    Arthroscopy; 2012 May; 28(5):595-605; quiz 606-10.e1. PubMed ID: 22542433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle-cell hip necrosis and intraosseous pressure.
    Mukisi MM; Bashoun K; Burny F
    Orthop Traumatol Surg Res; 2009 Apr; 95(2):134-8. PubMed ID: 19285936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hip septic arthritis in young children with sickle-cell disease].
    Akakpo-Numado GK; Gnassingbe K; Songne B; Amadou A; Tekou H
    Rev Chir Orthop Reparatrice Appar Mot; 2008 Feb; 94(1):58-63. PubMed ID: 18342031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with sickle cell disease.
    Menezes AS; Len CA; Hilário MO; Terreri MT; Braga JA
    Rev Paul Pediatr; 2013; 31(1):24-9. PubMed ID: 23703040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone and joint disease in sickle cell disease.
    Aguilar C; Vichinsky E; Neumayr L
    Hematol Oncol Clin North Am; 2005 Oct; 19(5):929-41, viii. PubMed ID: 16214653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal tubular dysfunction in children with sickle cell haemoglobinopathy.
    Badr M; El Koumi MA; Ali YF; El-Morshedy S; Almonem NA; Hassan T; El Rahman RA; Afify M
    Nephrology (Carlton); 2013 Apr; 18(4):299-303. PubMed ID: 23432792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of enuresis and its impact in quality of life of patients with sickle cell disease.
    Nelli AM; Mrad FCC; Alvaia MA; Maia HAADS; Guimarães COS; Carvalho ESS; Gomes CM; Bastos JM; de Bessa J
    Int Braz J Urol; 2019; 45(5):974-980. PubMed ID: 31626520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of health-related quality of life, work status, and health care utilization and costs according to hip and knee joint disease severity: a national Australian study.
    Ackerman IN; Ademi Z; Osborne RH; Liew D
    Phys Ther; 2013 Jul; 93(7):889-99. PubMed ID: 23559526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
    Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mediating effects of family functioning on psychosocial outcomes in healthy siblings of children with sickle cell disease.
    Gold JI; Treadwell M; Weissman L; Vichinsky E
    Pediatr Blood Cancer; 2011 Dec; 57(6):1055-61. PubMed ID: 21360652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the oral condition of children with sickle cell disease on family quality of life.
    Fernandes ML; Kawachi I; Corrêa-Faria P; Paiva SM; Pordeus IA
    Braz Oral Res; 2016; 30():. PubMed ID: 26910017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in patients with sickle cell disease in Jamaica: rural-urban differences.
    Asnani MR; Reid ME; Ali SB; Lipps G; Williams-Green P
    Rural Remote Health; 2008; 8(2):890. PubMed ID: 18410222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip problems in systemic disease.
    Funk FJ
    Clin Orthop Relat Res; 1973; (90):2-3. PubMed ID: 4569906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.